Literature DB >> 21264898

Case-control study of risk factors of myelodysplastic syndromes according to World Health Organization classification in a Chinese population.

Ling Lv1, Guowei Lin, Xiang Gao, Cuie Wu, Junmin Dai, Yongchen Yang, Hejian Zou, Hengjuan Sun, Minghua Gu, Xi Chen, Hua Fu, Liming Bao.   

Abstract

Risk factors of mydelodysplastic syndromes (MDS) remain largely unknown. We conducted a hospital-based case-control study consisting of 403 newly diagnosed MDS patients according to World Health Organization classification and 806 individually gender and age-matched patient controls from 27 major hospitals in Shanghai, China, to examine relation of lifestyle, environmental, and occupational factors to risk of MDS. The study showed that all MDS (all subtypes combined) risk factors included anti tuberculosis drugs [odds ratio (OR)(adj) = 3.15; 95% confidence interval (CI) = 1.22-8.12] as an independent risk factor, benzene (OR(adj) = 3.73; 95% CI = 1.32-10.51), hair dye use (OR = 1.46; 95% CI = 1.03-2.07), new building and renovations (OR = 1.69; 95% CI = 1.11-2.00), pesticides (OR = 2.16; 95% CI = 1.22-3.82), and herbicides (OR = 5.33; 95% CI = 1.41-20.10) as relative risk factors. Risk factors of MDS subtype refractory cytopenia with multiple dysplasia (RCMD) were benzene (OR(adj) = 5.99; 95% CI = 1.19-30.16) and gasoline (OR(adj) = 11.44; 95% CI = 1.31-100.03) as independent risk factors, and traditional Chinese medicines (OR = 2.17; 95% CI = 1.15-4.07), pesticides (OR = 2.92; 95% CI = 1.37-6.25), and herbicides (OR = 12.00; 95% CI = 1.44-99.67) as relative risk factors. Smoking tobacco was significantly associated with refractory anemia with excess of blasts (RAEB) (OR(adj) = 2.43; 95% CI = 1.02-5.77). Education is shown as an independent protective factor against all MDS (OR(adj) = 0.90; 95% CI = 0.83-0.99) and RCMD (OR(adj) = 0.89; 95% CI = 0.79-0.99). These findings suggest that multiple modifiable behavioral, environmental, and occupational factors play a role in MDS etiology, and various MDS subtypes may have different susceptibility.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264898     DOI: 10.1002/ajh.21941

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  14 in total

1.  Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.

Authors:  Jenny N Poynter; Michaela Richardson; Michelle Roesler; Cindy K Blair; Betsy Hirsch; Phuong Nguyen; Adina Cioc; James R Cerhan; Erica Warlick
Journal:  Int J Cancer       Date:  2016-09-24       Impact factor: 7.396

2.  Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studies.

Authors:  Jie Jin; Mengxia Yu; Chao Hu; Li Ye; Lili Xie; Feifei Chen; Zhengping Zhuang; Hongyan Tong
Journal:  Mol Clin Oncol       Date:  2014-08-07

3.  Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes.

Authors:  Amy M Linabery; Michelle A Roesler; Michaela Richardson; Erica D Warlick; Phuong L Nguyen; Adina M Cioc; Jenny N Poynter
Journal:  Cancer Epidemiol       Date:  2022-01-05       Impact factor: 2.984

4.  Myelodysplasia: new approaches.

Authors:  Karen Seiter
Journal:  Curr Treat Options Oncol       Date:  2013-06

5.  A Meta-Analysis of the Relationship between Cigarette Smoking and Incidence of Myelodysplastic Syndromes.

Authors:  Hongyan Tong; Chao Hu; Xiufeng Yin; Mengxia Yu; Jun Yang; Jie Jin
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

6.  Cigarette Smoking and the Risk of Adult Myeloid Disease: A Meta-Analysis.

Authors:  Peng Wang; Huifang Liu; Ting Jiang; Julun Yang
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

Review 7.  Spotlight on decitabine for myelodysplastic syndromes in Chinese patients.

Authors:  Yu Jing; Xue Shen; Qian Mei; Weidong Han
Journal:  Onco Targets Ther       Date:  2015-10-03       Impact factor: 4.147

8.  Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).

Authors:  Rina Yarosh; Michelle A Roesler; Thomas Murray; Adina Cioc; Betsy Hirsch; Phuong Nguyen; Erica Warlick; Jenny N Poynter
Journal:  Cancer Causes Control       Date:  2021-01-04       Impact factor: 2.506

9.  Myelodysplastic syndrome and benzene exposure among petroleum workers: an international pooled analysis.

Authors:  A Robert Schnatter; Deborah C Glass; Gong Tang; Richard D Irons; Lesley Rushton
Journal:  J Natl Cancer Inst       Date:  2012-10-30       Impact factor: 13.506

Review 10.  Acquired myelodysplasia or myelodysplastic syndrome: clearing the fog.

Authors:  Ethan A Natelson; David Pyatt
Journal:  Adv Hematol       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.